Ventricular Assist Device Clinical Trial
Official title:
Early Feasibility Study of the Supira System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (HRPCI) - The SUPPORT I Trial
The objective of this study is to assess the feasibility and safety of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. The clinical data may be used to support subsequent regulatory applications and further evaluation of the Supira System.
The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent high-risk percutaneous coronary interventions (HRPCI) performed in hemodynamically stable patients with severe coronary artery disease when a heart team, including a cardiac surgeon, has determined HRPCI is the appropriate therapeutic option. Use of the Supira System in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and postprocedural adverse events ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05612555 -
Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation
|
||
| Completed |
NCT04526964 -
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
|
N/A | |
| Completed |
NCT04234230 -
Improved Self-management for Patients on Ventricular Assist Device (VAD)
|
||
| Completed |
NCT03843021 -
Ventricular Assist Device (VAD) Infection Prevention Survey
|
||
| Recruiting |
NCT04613401 -
Influence of Telemonitoring on the Management of LVAD-patients
|